European Archives - Page 992 of 1132 - European Medical Journal

Interventional Cardiology

EMJ Interventional Cardiology 4.1 2016

Welcome to the 2016 edition of EMJ Interventional Cardiology, an assortment of the latest news, research, and opinions from across the world from…

How Bioresorbable Vascular Can Be Beneficial for Patients in the Long-Term

Coronary artery disease (CAD) is the leading cause of mortality in patients ≥60 years old worldwide, and may result in stable angina, acute coronary…

Zika Experts: Varied Neurological Complications, Virus Still Detectable After Recovery

London, 14 July, 2016 – The International Congress on Neuromuscular Diseases (ICND) just drew to an end in Toronto. Among the many questions addressed…

U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets Intended to Treat Soil-Transmitted Helminthiasis

Janssen Pharmaceuticals, Inc. announced that the U.S. FDA has granted Priority Review designation for the New Drug Application for a 500mg chewable tablet formulation of mebendazole

Introducing EMJ Neurology 4.1

Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…

EMJ

A Call from a Patient to Openly Discuss Body Image in the Treatment of Type 1 Diabetes

Diabetes is a non-communicable disease (NCD) meaning that it often cannot be seen. After 20 years of living with Type 1 diabetes I am lucky to have no…

Review of the 2nd European Academy of Neurology Congress 2016

Although history and tradition are hallmarks of Danish culture, recent developments have created a hub of modern Danish trademarks in Copenhagen. Hosted…

EMJ Neurology 4.1 2016

Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…

Brain Health: Translating Scientific Evidence Into Clinical Practice in Multiple Sclerosis

Brain volume loss (BVL) progresses more rapidly in patients with multiple sclerosis (MS) than in healthy individuals, and brain atrophy begins early in…

Editor’s Pick: Clinical Significance of Apathy in Parkinson’s Disease

Apathy, or lack of motivation, is increasingly recognised as a major factor affecting quality of life and prognosis in Parkinson’s disease (PD)…